RECENT NEWS

The UK Health Security Agency (UKHSA) has appointed Professor Robin May as Interim Chief Scientific Officer on a one-year appointment.

The Serious Hazards of Transfusion (SHOT) scheme has launched the UK’s first blood transfusion information app, co-created with patients, for patients.

More than 40 pivotal studies will be unveiled during the ten Hot Line sessions at ESC Congress 2025, the largest cardiovascular congress globally. The annual congress of the European Society of Cardiology is held in collaboration with the World Congress of Cardiology in Madrid from 29 August to 1 September.

A new strategy aiming to revolutionise care and improve experience using the latest digital advances and AI has been launched at one of the country’s leading children’s hospitals.

Digostics, the UK-based health tech company behind the world’s first oral glucose intolerance test (OGTT) that can be done at home instead of a clinic or hospital, has announced it has surpassed £500,000 in funding on the Crowdcube equity crowdfunding platform, with more than 100 investors backing the company’s mission to revolutionise diabetes detection and monitoring.

Major new investment in an innovative approach to helping provide better care in the community is set to be a ‘game-changer’ for Scotland’s growing frail population, according to a formal NHS partner.

A new world-leading biosecurity centre in Harlow, Essex will protect the UK from emerging public health threats and boost economic growth. The national biosecurity centre (NBC) will increase the speed and scale of research into dangerous pathogens and life-saving vaccines, boosting healthcare and economic growth, and protecting UK national security.

The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD (metabolic dysfunction-associated steatotic liver disease – previously called non-alcoholic fatty liver disease), suggests an analysis as part of The Lancet Commission on liver cancer.

Consultants at The Royal Orthopaedic Hospital NHS Foundation Trust are at the forefront of research into whether intervening with radiotherapy immediately following surgery to treat pathological fractures reduces pain significantly, compared to no intervention. This is being undertaken as part of the PORTRAIT trial (Post Operative Radiotherapy in Surgically Treated Bone Metastases), a multi-centre study funded by the National Institute for Health and Care Research (NIHR).

Women who are overdue for cervical cancer screening are most likely to participate in screening when a self-sampling kit is offered by a healthcare professional as part of routine GP appointments

The Royal College of Surgeons of England (RCS England) has warned that the waiting list for hospital treatment in Wales has risen after three months of progress. In May 2025, 796,148 patient pathways were waiting for treatment, up from 789,929 in April 2025.

A new study has found that the bone fracture protection women get from menopausal hormone therapy (MHT, also known as HRT) disappears within a year of stopping treatment.

A Shropshire manufacturer of premium hygiene and decontamination products has appointed a third generation family member following the successful completion of the firm’s graduate development programme.

Speaking to CSJ’s Editor in an exclusive interview, at EBME Expo 2025, Löwenstein Medical’s Richard Glover highlighted the latest advances in neonatal ventilation.

At EBME Expo, sustainability and safety were high on the agenda. The refurbishment and repair of medical devices is an important aspect in delivering a more sustainable NHS, reducing waste and costs for healthcare providers.

Patients are coming to harm due to failures in the way critical clinical information is electronically communicated when they are discharged from hospital, according to HSSIB’s latest report.

NHS Resolution’s Annual Report for 2024/25 shows that it received 14,428 new clinical negligence claims and reported incidents in 2024/25. £3.1 billion was paid out in 2024/25 for compensation and associated costs on all of NHS Resolution’s clinical schemes, compared to £2.8 billion in 2023/24. £1.3 billion of the total clinical negligence payments in 2024/25 related to maternity.

In one of the first cases in the world, a baby was born at Rabin Medical Center, Beilinson Hospital (RMC), in Israel, to a woman who had undergone uterine transposition surgery. This ground-breaking procedure is designed to preserve fertility in women diagnosed with cancer in the pelvic organs before undergoing radiation treatment. This baby is the sixth in the world born to a woman who has undergone this procedure.

Exposure to a class of synthetic chemicals known as per- and polyfluoroalkyl substances (PFAS) - often called “forever chemicals” - may increase the risk of developing type 2 diabetes, according to a new study led by Mount Sinai researchers.

Molecules exhaled in the breath may help detect blood cancer, according to new research from Queen Mary University of London. The findings could enable the development of a blood cancer breathalyser, providing a rapid, low-cost way to detect disease. This tool may be particularly useful for areas with limited access to specialist equipment or expertise.